Back to medical news
MedPage Today
Second-Season RSV Immunization Worked for Eligible Children
October 22, 2026
Original source summary
(MedPage Today) -- WASHINGTON -- Real-world data backed the effectiveness of second-season nirsevimab (Beyfortus) immunizations against hospitalizations for children at high risk for severe respiratory syncytial virus (RSV) illness. In the case...
Verbatim from MedPage Today's own feed — "Second-Season RSV Immunization Worked for Eligible Children"
Want more like this?
Browse more from the feed. A free account unlocks the full feed, saving and communities.
More medical news